Please assess the completion status of the following clinical trial:

Trial Title: Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with planned interruption of chronic clopidogrel therapy after DES implantation~* Informed, written consent by the patient~Exclusion Criteria:~* Planned surgery within the next month~* Active bleeding as reason for clopidogrel discontinuation~* Concomitant coumadin therapy~* Pregnancy (present, suspected or planned) or positive pregnancy test (In women with childbearing potential a negative pregnancy test is mandatory)~* Malignancies or other comorbid conditions with a life expectancy of less than one year or that may result in protocol noncompliance.~* Patient's inability to fully comply with the study protocol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clopidogrel Tapering (Type: ACTIVE_COMPARATOR): None
- Abrupt Clopidogrel Interruption (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).